annual EBITDA:
$5.04B+$373.50M(+8.01%)Summary
- As of today (May 29, 2025), CME annual EBITDA is $5.04 billion, with the most recent change of +$373.50 million (+8.01%) on December 31, 2024.
- During the last 3 years, CME annual EBITDA has risen by +$1.11 billion (+28.36%).
- CME annual EBITDA is now at all-time high.
Performance
CME EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBITDA:
$1.37B+$148.30M(+12.15%)Summary
- As of today (May 29, 2025), CME quarterly EBITDA is $1.37 billion, with the most recent change of +$148.30 million (+12.15%) on March 31, 2025.
- Over the past year, CME quarterly EBITDA has increased by +$130.40 million (+10.53%).
- CME quarterly EBITDA is now at all-time high.
Performance
CME quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
$5.17B+$130.40M(+2.59%)Summary
- As of today (May 29, 2025), CME TTM EBITDA is $5.17 billion, with the most recent change of +$130.40 million (+2.59%) on March 31, 2025.
- Over the past year, CME TTM EBITDA has increased by +$550.80 million (+11.93%).
- CME TTM EBITDA is now at all-time high.
Performance
CME TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
CME EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +8.0% | +10.5% | +11.9% |
| 3 y3 years | +28.4% | +30.3% | +26.6% |
| 5 y5 years | +50.8% | +19.8% | +40.4% |
CME EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +28.4% | at high | +42.9% | at high | +29.4% |
| 5 y | 5-year | at high | +50.8% | at high | +96.6% | at high | +66.7% |
| alltime | all time | at high | >+9999.0% | at high | +4018.8% | at high | >+9999.0% |
CME EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $1.37B(+12.1%) | $5.17B(+2.6%) |
| Dec 2024 | $5.04B(+8.0%) | $1.22B(-6.2%) | $5.04B(+1.8%) |
| Sep 2024 | - | $1.30B(+1.7%) | $4.95B(+4.2%) |
| Jun 2024 | - | $1.28B(+3.2%) | $4.75B(+2.9%) |
| Mar 2024 | - | $1.24B(+9.4%) | $4.62B(-1.0%) |
| Dec 2023 | $4.67B(+16.2%) | $1.13B(+2.7%) | $4.67B(+3.9%) |
| Sep 2023 | - | $1.10B(-3.8%) | $4.49B(+2.1%) |
| Jun 2023 | - | $1.15B(-10.9%) | $4.40B(+3.5%) |
| Mar 2023 | - | $1.29B(+34.2%) | $4.25B(+5.8%) |
| Dec 2022 | $4.02B(+2.3%) | $957.80M(-5.2%) | $4.02B(+0.6%) |
| Sep 2022 | - | $1.01B(+1.4%) | $3.99B(-5.3%) |
| Jun 2022 | - | $996.70M(-5.1%) | $4.22B(+3.2%) |
| Mar 2022 | - | $1.05B(+12.3%) | $4.08B(+4.0%) |
| Dec 2021 | $3.93B(+17.1%) | $935.70M(-24.2%) | $3.93B(+6.5%) |
| Sep 2021 | - | $1.23B(+42.8%) | $3.69B(+17.1%) |
| Jun 2021 | - | $864.30M(-3.1%) | $3.15B(+1.5%) |
| Mar 2021 | - | $892.00M(+27.9%) | $3.10B(-7.5%) |
| Dec 2020 | $3.35B(+0.4%) | $697.20M(+0.1%) | $3.35B(-2.5%) |
| Sep 2020 | - | $696.20M(-14.7%) | $3.44B(-5.3%) |
| Jun 2020 | - | $816.50M(-28.6%) | $3.63B(-1.4%) |
| Mar 2020 | - | $1.14B(+46.1%) | $3.68B(+10.2%) |
| Dec 2019 | $3.34B(+4.9%) | $782.20M(-11.8%) | $3.34B(-0.9%) |
| Sep 2019 | - | $887.20M(+2.0%) | $3.37B(+7.2%) |
| Jun 2019 | - | $869.60M(+8.4%) | $3.14B(+0.9%) |
| Mar 2019 | - | $801.90M(-1.2%) | $3.12B(-2.2%) |
| Dec 2018 | $3.18B(+11.7%) | $811.90M(+22.9%) | $3.18B(+5.2%) |
| Sep 2018 | - | $660.70M(-21.4%) | $3.03B(-0.9%) |
| Jun 2018 | - | $841.00M(-3.4%) | $3.05B(+4.2%) |
| Mar 2018 | - | $870.60M(+32.8%) | $2.93B(+2.8%) |
| Dec 2017 | $2.85B(+8.2%) | $655.40M(-4.6%) | $2.85B(-1.0%) |
| Sep 2017 | - | $687.10M(-4.5%) | $2.88B(+1.8%) |
| Jun 2017 | - | $719.10M(-9.0%) | $2.83B(+2.4%) |
| Mar 2017 | - | $790.20M(+15.6%) | $2.76B(+4.7%) |
| Dec 2016 | $2.64B(+14.5%) | $683.60M(+7.6%) | $2.64B(+5.2%) |
| Sep 2016 | - | $635.10M(-2.5%) | $2.51B(+1.3%) |
| Jun 2016 | - | $651.50M(-2.2%) | $2.47B(+4.9%) |
| Mar 2016 | - | $666.20M(+20.3%) | $2.36B(+2.3%) |
| Dec 2015 | $2.30B(+8.4%) | $553.70M(-8.0%) | $2.30B(-0.2%) |
| Sep 2015 | - | $602.00M(+12.5%) | $2.31B(+3.9%) |
| Jun 2015 | - | $535.00M(-12.6%) | $2.22B(+1.1%) |
| Mar 2015 | - | $612.10M(+9.5%) | $2.20B(+3.4%) |
| Dec 2014 | $2.12B(+6.7%) | $558.90M(+8.4%) | $2.12B(+7.8%) |
| Sep 2014 | - | $515.80M(+1.2%) | $1.97B(+1.1%) |
| Jun 2014 | - | $509.90M(-5.5%) | $1.95B(-4.7%) |
| Mar 2014 | - | $539.40M(+33.0%) | $2.04B(+2.7%) |
| Dec 2013 | $1.99B | $405.50M(-17.9%) | $1.99B(-2.5%) |
| Sep 2013 | - | $494.10M(-18.4%) | $2.04B(+0.4%) |
| Jun 2013 | - | $605.80M(+24.9%) | $2.03B(+0.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2013 | - | $485.10M(+6.1%) | $2.03B(-2.2%) |
| Dec 2012 | $2.08B(-10.2%) | $457.30M(-6.0%) | $2.08B(-0.4%) |
| Sep 2012 | - | $486.70M(-19.5%) | $2.09B(-6.9%) |
| Jun 2012 | - | $604.50M(+14.0%) | $2.24B(+0.1%) |
| Mar 2012 | - | $530.20M(+14.0%) | $2.24B(-3.3%) |
| Dec 2011 | $2.31B(+9.1%) | $465.00M(-27.4%) | $2.31B(-2.6%) |
| Sep 2011 | - | $640.30M(+6.2%) | $2.38B(+5.5%) |
| Jun 2011 | - | $602.70M(-0.5%) | $2.25B(+0.9%) |
| Mar 2011 | - | $605.90M(+15.0%) | $2.23B(+5.3%) |
| Dec 2010 | $2.12B(+16.3%) | $526.70M(+1.9%) | $2.12B(+3.7%) |
| Sep 2010 | - | $517.10M(-11.3%) | $2.04B(+3.3%) |
| Jun 2010 | - | $583.10M(+18.2%) | $1.98B(+6.2%) |
| Mar 2010 | - | $493.30M(+9.5%) | $1.86B(+2.2%) |
| Dec 2009 | $1.82B(+14.5%) | $450.50M(-0.1%) | $1.82B(+14.5%) |
| Sep 2009 | - | $450.90M(-3.7%) | $1.59B(-3.3%) |
| Jun 2009 | - | $468.40M(+3.2%) | $1.65B(+4.5%) |
| Mar 2009 | - | $453.70M(+106.5%) | $1.58B(+0.1%) |
| Dec 2008 | $1.59B(+30.6%) | $219.70M(-56.6%) | $1.57B(-9.6%) |
| Sep 2008 | - | $506.00M(+27.5%) | $1.74B(+6.6%) |
| Jun 2008 | - | $396.79M(-12.1%) | $1.63B(+12.1%) |
| Mar 2008 | - | $451.37M(+16.6%) | $1.46B(+18.8%) |
| Dec 2007 | $1.22B(+75.1%) | $387.00M(-2.9%) | $1.23B(+20.5%) |
| Sep 2007 | - | $398.36M(+81.1%) | $1.02B(+27.9%) |
| Jun 2007 | - | $219.95M(-0.6%) | $795.54M(+3.7%) |
| Mar 2007 | - | $221.19M(+24.1%) | $766.97M(+9.2%) |
| Dec 2006 | $696.18M(+27.5%) | $178.28M(+1.2%) | $702.58M(+6.9%) |
| Sep 2006 | - | $176.13M(-8.0%) | $657.42M(+6.2%) |
| Jun 2006 | - | $191.38M(+22.1%) | $618.98M(+4.2%) |
| Mar 2006 | - | $156.80M(+17.8%) | $593.76M(+5.1%) |
| Dec 2005 | $545.85M(+32.4%) | $133.12M(-3.3%) | $564.70M(+9.1%) |
| Sep 2005 | - | $137.69M(-17.1%) | $517.42M(+3.9%) |
| Jun 2005 | - | $166.16M(+30.1%) | $498.07M(+11.5%) |
| Mar 2005 | - | $127.73M(+48.8%) | $446.67M(+8.3%) |
| Dec 2004 | $412.35M(+59.1%) | $85.83M(-27.5%) | $412.35M(+7.6%) |
| Sep 2004 | - | $118.34M(+3.1%) | $383.05M(+15.0%) |
| Jun 2004 | - | $114.75M(+22.8%) | $333.17M(+13.7%) |
| Mar 2004 | - | $93.42M(+65.2%) | $293.01M(+13.1%) |
| Dec 2003 | $259.14M(+15.2%) | $56.53M(-17.4%) | $259.14M(-2.3%) |
| Sep 2003 | - | $68.46M(-8.2%) | $265.29M(+6.1%) |
| Jun 2003 | - | $74.59M(+25.3%) | $249.92M(+9.0%) |
| Mar 2003 | - | $59.55M(-5.0%) | $229.31M(+8.1%) |
| Dec 2002 | $224.88M(+39.3%) | $62.68M(+18.0%) | $212.14M(+14.3%) |
| Sep 2002 | - | $53.10M(-1.6%) | $185.59M(+4.1%) |
| Jun 2002 | - | $53.98M(+27.4%) | $178.21M(+13.2%) |
| Mar 2002 | - | $42.38M(+17.3%) | $157.46M(+36.8%) |
| Dec 2001 | $161.48M(+535.6%) | $36.13M(-21.0%) | $115.08M(+45.8%) |
| Sep 2001 | - | $45.72M(+37.5%) | $78.96M(+137.5%) |
| Jun 2001 | - | $33.24M | $33.24M |
| Dec 2000 | $25.41M | - | - |
FAQ
- What is CME annual EBITDA?
- What is the all time high annual EBITDA for CME?
- What is CME annual EBITDA year-on-year change?
- What is CME quarterly EBITDA?
- What is the all time high quarterly EBITDA for CME?
- What is CME quarterly EBITDA year-on-year change?
- What is CME TTM EBITDA?
- What is the all time high TTM EBITDA for CME?
- What is CME TTM EBITDA year-on-year change?
What is CME annual EBITDA?
The current annual EBITDA of CME is $5.04B
What is the all time high annual EBITDA for CME?
CME all-time high annual EBITDA is $5.04B
What is CME annual EBITDA year-on-year change?
Over the past year, CME annual EBITDA has changed by +$373.50M (+8.01%)
What is CME quarterly EBITDA?
The current quarterly EBITDA of CME is $1.37B
What is the all time high quarterly EBITDA for CME?
CME all-time high quarterly EBITDA is $1.37B
What is CME quarterly EBITDA year-on-year change?
Over the past year, CME quarterly EBITDA has changed by +$130.40M (+10.53%)
What is CME TTM EBITDA?
The current TTM EBITDA of CME is $5.17B
What is the all time high TTM EBITDA for CME?
CME all-time high TTM EBITDA is $5.17B
What is CME TTM EBITDA year-on-year change?
Over the past year, CME TTM EBITDA has changed by +$550.80M (+11.93%)